跳至主要内容
临床试验/NCT07355231
NCT07355231尚未招募1 期

Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI

Xemed LLC0 个研究点目标入组 10 人开始时间: 2027年3月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
尚未招募
发起方
Xemed LLC
入组人数
10
主要终点
Changes in DLCO at 6-month post RT treatment.

研究概览

简要总结

Cancer radiation treatment plans that employ lung functional avoidance methods require 3D maps that differentiate regions of healthy lung function from regions of functional compromised tissue to deliver sufficient dose to the tumor while preserving as much functioning lung as possible. Hyperpolarized xenon-129 MRI can provide maps of ventilatory function and gas exchange to the bloodstream. Improving treatment plans based on this novel imaging modality could reduce risk or severity of radiation pneumonitis and improve post-treatment quality of life.

详细描述

Customized 3D planning of radiation therapy for lung cancer delivers a lethal dose to the tumor region while avoiding important structures (spine) and organs (esophagus, heart, lungs). Since radiation dose to functioning lung is associated with acute radiation pneumonitis and chronic radiation fibrosis, researchers seek to shift dosage preferentially away from lung regions with highest function. Several lung functional imaging modalities have been investigated (ventilation-perfusion SPECT and PET, 4DCT, hyperpolarized 3He). These studies indicate that regional ventilation is not the optimal biometric. What is needed is a high-resolution imaging modality, tolerable to patients who have difficulty holding their breath, that delineates regions of full lung function warranting preservation, and also identifies regions whose function is irrevocably gone.

The investigators propose a translational study applying Hyperpolarized Xenon (HXe) MRI to improve lung-health outcomes for lung cancer patients treated with radiation therapy. This study will focus on a patient cohort with significant heterogeneity: new patients with lung cancer and GOLD stage 3+ emphysema as a comorbidity and patients receiving RT for their second (primary) lung cancer. Optimizing radiation therapy treatment plans could provide a statistically significant benefit within a manageably small patient cohort. Maps will delineate three regions of functionality: regions of full function, having both ventilation and gas exchange to blood (where radiation should be avoided or minimized), regions where function is irrevocably absent (where radiation dose can be increased/maximized), and regions where function may be present or recoverable (where radiation should remain below or at the normal dose limit). Regions of lungs with absent function will have highest priority for receiving radiation during the RT procedure, while healthy regions will be avoided. It is expected that following this functional avoidance procedure will result in a decrease in the radiation induced lung injury reported events and a better outcome of the radiation treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over 18 years with a diagnosis of non-small lung cancer and planned for a definitive course of radiation therapy.
  • Preferred patients will have had successful radiation therapy for a prior lung cancer and developed a secondary lung cancer for which are to be treated.
  • Other de-nuovo lung cancer patients planned for radiation therapy with lung heterogeneity from natural co-morbidities (e.g., COPD stage 3+).

排除标准

  • Patients less than 18 years old
  • Patients known to be pregnant - a positive pregnancy test will be used to respectively exclude pregnant patients,
  • Any known contraindication to MRI examination
  • Anyone with an implanted metal device
  • Inability to provide informed consent
  • A language, communication, cognitive or behavioral impairment that might interfere with fully informed participation in the study.
  • History of uncompensated organ failure (i.e. organ failure that is not stabilized through medical intervention), which will be assessed by the PI.
  • Homelessness or other unstable living situation
  • Active drug or alcohol dependence
  • Claustrophobia
  • Subjects weighting more than 300 pounds.
  • Subjects with chest size larger than the bore of MRI machine can accommodate

研究组 & 干预措施

Guided Radiation Therapy for lung cancer using HXe MRI for functional lung avoidance and diagnosis.

Experimental

Patients with non-small cell lung cancer scheduled for radiation therapy will be voluntarily enrolled in this study. They will have their lung ventilation and function imaged with hyperpolarized xenon MRI. The 3D HXe images will be used in determining a functional lung avoidance treatment map. Patients will follow radiation therapy optimized for functional lung avoidance. At 6-month follow up the subjects will be imaged again with HXe to assess lung ventilation and function post-RT compared to baseline (pre-RT). Additionally, standard-of-care lung testing (DLCO, PFT) and quality-of-life questionnaires will be assessed at several time points during the study.

干预措施: Hyperpolarized xenon MRI (Combination Product)

结局指标

主要结局

Changes in DLCO at 6-month post RT treatment.

时间窗: 1-year

Subjects will have measurements of DLCO at baseline (before RT) and at 6-month post RT. An independent-sample t-test will be used to compare change in DLCO.

次要结局

  • Change in Quality of Life questionnaires from baseline to 6-month post-RT.(1-year)
  • Change in HXe lung MRI metrics from baseline to 6-month post-RT.(1-year)
  • Change in FEV1 from baseline to 6-month post-RT.(1-year)
  • Incidence/severity of pneumonitis.(1-year)

研究者

发起方
Xemed LLC
申办方类型
Industry
责任方
Sponsor

相似试验